NASDAQ:JKIiShares Morningstar Mid-Cap Value ETF Stock Price, Forecast & News

iShares Morningstar Mid-Cap Value ETF's stock was trading at $124.61 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, JKI stock has increased by 9.8% and is now trading at $136.81.
View which stocks have been most impacted by Coronavirus.

iShares Morningstar Mid-Cap Value ETF declared a quarterly dividend on Wednesday, March 25th. Investors of record on Thursday, March 26th will be paid a dividend of $1.4735 per share on Tuesday, March 31st. This represents a $5.89 annualized dividend and a yield of 4.31%. The ex-dividend date is Wednesday, March 25th. This is a boost from iShares Morningstar Mid-Cap Value ETF's previous quarterly dividend of $1.23.
View iShares Morningstar Mid-Cap Value ETF's dividend history.

Press coverage about JKI stock has trended negative recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. iShares Morningstar Mid-Cap Value ETF earned a daily sentiment score of -2.2 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days.
View the latest news about iShares Morningstar Mid-Cap Value ETF.

iShares Morningstar Mid-Cap Value ETF saw a drop in short interest in the month of March. As of March 13th, there was short interest totaling 800 shares, a drop of 38.5% from the February 27th total of 1,300 shares. Based on an average trading volume of 26,400 shares, the days-to-cover ratio is currently 0.0 days.
View iShares Morningstar Mid-Cap Value ETF's Short Interest.

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Morningstar Mid-Cap Value ETF investors own include Rhythm Pharmaceuticals (RYTM), Reckitt Benckiser Group (RB), Pzena Investment Management (PZN), PepsiCo (PEP), Meredith (MDP), Mastercard (MA), 1st Tr EXCHANGE/MATLS ALPHADEX FDAN (FXZ), Forrester Research (FORR), Enphase Energy (ENPH) and Crinetics Pharmaceuticals (CRNX).

iShares Morningstar Mid-Cap Value ETF trades on the NASDAQ under the ticker symbol "JKI."

iShares Morningstar Mid-Cap Value ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Matrix Trust Co (4.15%), Commonwealth Equity Services LLC (1.55%), GHP Investment Advisors Inc. (1.11%), Raymond James & Associates (1.09%), UBS Group AG (1.00%) and Raymond James Financial Services Advisors Inc. (0.86%).

JKI stock was sold by a variety of institutional investors in the last quarter, including Commonwealth Equity Services LLC, Matrix Trust Co, Marietta Wealth Management LLC, Raymond James Financial Services Advisors Inc., Burt Wealth Advisors, CWM LLC, Nwam LLC, and Courage Miller Partners LLC.

JKI stock was acquired by a variety of institutional investors in the last quarter, including Raymond James & Associates, Pflug Koory LLC, Envestnet Asset Management Inc., GHP Investment Advisors Inc., Islay Capital Management LLC, and UBS Group AG.

Shares of JKI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of JKI stock can currently be purchased for approximately $136.81.

iShares Morningstar Mid-Cap Value ETF has a market capitalization of $348.87 million.

The official website for iShares Morningstar Mid-Cap Value ETF is www.ishares.com.

iShares Morningstar Mid-Cap Value ETF's mailing address is 45 Fremont Street, San Francisco, 94105, United States. The company can be reached via phone at +1-800-4742737.